查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1830950

血管通路设备市场

Vascular Access Devices Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

2024 年血管通路设备市场价值为 65.1 亿美元，预计到 2031 年将达到 111 亿美元，2025 年至 2031 年的复合年增长率预计为 7.9%。

市场洞察与分析师观点：血管通路装置可经由各种解剖部位进入上腔静脉或下腔静脉，包括颈内静脉、锁骨下静脉、颈外静脉和股静脉。血管通路装置市场的扩张主要受慢性病发病率上升和化疗需求成长的驱动。此外，企业为维持市场竞争力而采取的策略行动也促进了这一成长。预计在预测期内，人工智慧机器人静脉通路装置的采用率将显着上升，这将为血管通路装置市场带来新的趋势。

成长因素与挑战：化疗是一种主要或辅助治疗方法，旨在透过强效药物治疗来减少或根除肿瘤。因此，癌症病例的增加增加了对化疗的需求。根据国际癌症研究机构 (IARC) 的数据，2020 年全球报告新增癌症病例 1,930 万例，导致约 1,000 万人死亡。南非国家癌症登记处 (NCR) 报告称，2020 年新增癌症诊断病例约 11 万例，癌症相关死亡病例超过 56,000 例。此外，预计未来几十年疾病负担将加剧，预计到 2030 年和 2040 年新增癌症病例将分别达到 138,000 例和 175,000 例，而癌症相关死亡人数预计将分别上升至 73,000 例和 94,000 例。因此，癌症发生率的上升推动了血管通路设备市场的成长。

战略洞察

报告细分和范围：透过检查以下细分市场对血管通路设备市场进行分析：产品类型、应用、插入途径、最终用户和地理位置。市场依产品类型分为短週边静脉导管、中线导管、PICC（週边插入中心静脉导管）、中心静脉导管、植入式连接埠和配件。中心静脉导管部分进一步分为CICC（中心插入中心静脉导管）、FICC（股动脉插入中心静脉导管）等。在应用方面，血管通路设备市场细分为药物管理、液体和营养管理、血液製品输血等。插入途径将市场分为皮下和静脉内。依最终用户细分，市场分为医院和诊所、门诊手术中心等。血管通路设备市场报告的地理范围包括北美（美国、加拿大和墨西哥）、欧洲（西班牙、英国、德国、法国、义大利和欧洲其他地区）、亚太地区（韩国、中国、日本、印度、澳洲和亚太其他地区）、中东和非洲（南非、沙乌地阿拉伯、阿联酋和中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地区）。

細項分析：血管通路设备市场按产品类型细分为短週边静脉导管、中线导管、PICC（週边插入中心静脉导管）、中心静脉导管、植入式输液港和配件。中心静脉导管细分市场进一步细分为CICC（中心静脉插入中心静脉导管）、FICC（股静脉插入中心静脉导管）和其他。 2022年，短週边静脉导管细分市场占据血管通路设备市场的最大份额，预计在2022年至2030年期间的复合年增长率最高。

就应用而言，血管通路设备市场分为药物管理、液体和营养管理、血液製品输注及其他。药物管理领域在2022年占据最大份额，预计在2022年至2030年期间将呈现最高的复合年增长率。

就插入途径而言，血管通路器械市场分为皮下和静脉。静脉通路在2022年占据了更大的市场份额，预计在2022年至2030年期间将实现更高的复合年增长率。

按最终用户划分，市场分为医院和诊所、门诊手术中心和其他。预计2022年至2030年期间，医院和诊所的血管通路设备市场将持续成长。

区域分析：北美是全球血管通路器械市场成长的主要贡献者。预计亚太地区将在2022年至2030年期间实现最高的复合年增长率。 2022年，北美占据了全球市场的最大份额，这得益于慢性病患病率的上升、老龄人口的增长、参与产品开发的关键市场参与者的存在以及技术的进步。在北美，美国在2022年占据了最大的市场。

血管通路设备市场报告范围

产业发展与未来机会：血管通路设备市场的预测是基于各种二手和一手研究成果，包括主要公司出版物、协会资料和资料库。根据主要市场参与者的新闻稿，概述了以下几种策略：

2023年11月，BD（碧迪公司）推出了与整合导管相容的新型无针采血技术，助力公司实现「一次扎针住院」的愿景。 PIVO Pro无针采血装置的设计已改进，可相容于整合式和长型週边静脉导管，包括配备NearPort静脉通路的新型Nexiva封闭式静脉导管系统。 2023年5月，泰利福公司推出了两款新设备——Arrow VPS Rhythm DLX设备和NaviCurve Stylet，旨在改善PICC置管流程并最大限度地减少併发症。 VPS Rhythm DLX设备利用患者的心电活动提供即时导管尖端位置资讯。 NaviCurve Stylet采用符合人体解剖学的曲线和灵活的尖端设计，可根据患者解剖结构进行自我定位，以便PICC更好地推进至上腔静脉(SVC)并成功置管。

竞争格局和主要公司：Teleflex Inc、BD、B. Braun SE、Terumo Medical Corporation、Medtronic、Fresenius Kabi、Baxter、Vygon SAS、Kimal 和 Access Vascular Inc 是血管通路设备市场报告中重点介绍的关键参与者。此外，报告还考察和分析了其他几家公司，以提供对市场及其生态系统的全面了解。这些公司专注于地理扩张和新产品发布，以满足全球消费者日益增长的需求，并增强其在专业产品组合中的供应。他们的全球影响力使他们能够满足庞大的客户群，从而促进市场成长。

目录

第一章：简介

第 2 章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：血管通路设备市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：血管通路设备市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：血管通路设备市场－全球市场分析

  • 血管通路设备 - 全球市场概览
  • 血管通路设备－全球市场及2030年预测

第七章：血管通路设备市场-收入分析-依类型，2020-2030

  • 概述
  • 短週边静脉导管
  • 中线导管
  • 中国人保中心
  • 中心导管
  • 植入式输液港
  • 配件

第 8 章：血管通路设备市场 - 收入分析 - 按应用，2020-2030 年

  • 概述
  • 药品管理局
  • 输血
  • 液体和营养管理
  • 其他的

第 9 章：血管通路设备市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第 10 章：血管通路设备市场 - 收入分析，2020-2030 年 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 13 章：血管通路设备市场 - 主要公司简介

  • B Braun Melsungen AG
  • NIPRO Medical Corporation
  • Smiths Medical
  • Becton, Dickinson, and Company
  • Terumo Corporation
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • AngioDynamics
  • Ameco Medical
  • Vygon Ltd

第 14 章：附录

简介目录
Product Code: TIPHE100000983

The vascular access devices market was valued at US$ 6.51 billion in 2024 and is anticipated to reach US$ 11.10 billion by 2031, with a projected CAGR of 7.9% from 2025 to 2031.

Market Insights and Analyst Perspective:Vascular access devices are utilized through various anatomical sites to access the superior or inferior vena cava, including the internal jugular vein, subclavian vein, external jugular vein, and femoral vein. The expansion of the vascular access devices market is primarily driven by the increasing incidence of chronic diseases and the growing demand for chemotherapy treatments. Furthermore, strategic actions by companies to maintain competitiveness in the market contribute to this growth. A notable rise in the adoption of AI-enabled robotic venous access devices is expected to introduce new trends in the vascular access device market throughout the forecast period.

Growth Factors and Challenges:Chemotherapy serves as a primary or adjunctive treatment aimed at reducing or eradicating tumors through potent drug administration. Consequently, the rising number of cancer cases boosts the demand for chemotherapy procedures. According to the International Agency for Research on Cancer (IARC), there were 19.3 million new cancer cases reported worldwide in 2020, resulting in approximately 10 million deaths. The National Cancer Registry (NCR) in South Africa reported around 110,000 new cancer diagnoses and over 56,000 cancer-related fatalities in 2020. Additionally, the disease burden is expected to escalate in the coming decades, with projections of new cancer cases reaching 138,000 and 175,000 by 2030 and 2040, respectively, while cancer-related deaths are anticipated to rise to 73,000 and 94,000 in those years. Thus, the increasing prevalence of cancer propels the growth of the vascular access devices market.

Strategic Insights

Report Segmentation and Scope:The analysis of the vascular access devices market has been conducted by examining the following segments: product type, application, route of insertion, end user, and geography. The market is categorized by product type into short peripheral intravenous catheters, midline catheters, PICC (peripherally inserted central catheters), central catheters, implantable ports, and accessories. The central catheter segment is further divided into CICC (centrally inserted central catheter), FICC (femorally inserted central catheter), and others. In terms of application, the vascular access devices market is segmented into drug administration, fluid and nutrition administration, blood product transfusion, and others. The route of insertion divides the market into subcutaneous and intravenous. By end users, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The geographical scope of the vascular access devices market report includes North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Segmental Analysis:The vascular access devices market is segmented by product type into short peripheral intravenous catheters, midline catheters, PICC (peripherally inserted central catheters), central catheters, implantable ports, and accessories. The central catheter segment is further divided into CICC (centrally inserted central catheter), FICC (femorally inserted central catheter), and others. In 2022, the short peripheral intravenous catheter segment held the largest share of the vascular access devices market and is projected to exhibit the highest CAGR from 2022 to 2030.

In terms of application, the vascular access devices market is divided into drug administration, fluid and nutrition administration, blood product transfusion, and others. The drug administration segment accounted for the largest share in 2022 and is expected to show the highest CAGR during the period from 2022 to 2030.

Regarding the route of insertion, the vascular access devices market is split into subcutaneous and intravenous. The intravenous segment captured a larger market share in 2022 and is predicted to achieve a higher CAGR from 2022 to 2030.

By end user, the market is categorized into hospitals and clinics, ambulatory surgical centers, and others. The vascular access devices market for hospitals and clinics is anticipated to grow during the period from 2022 to 2030.

Regional Analysis:North America is the leading contributor to the global growth of the vascular access devices market. The Asia Pacific region is expected to experience the highest CAGR in the market from 2022 to 2030. North America held the largest share of the global market in 2022, driven by the increasing prevalence of chronic conditions, a growing elderly population, the presence of key market players engaged in product development, and advancements in technology. In North America, the US accounted for the largest market share in 2022.

Vascular Access Devices Market Report Scope

Industry Developments and Future Opportunities:The forecast for the vascular access devices market is based on various secondary and primary research findings, including key company publications, association data, and databases. According to press releases from major market players, several strategies are outlined below:

In November 2023, BD (Becton, Dickinson, and Company) introduced new needle-free blood draw technology compatible with integrated catheters, supporting the company's vision of a "One-Stick Hospital Stay." The PIVO Pro Needle-free Blood Collection Device features design enhancements for compatibility with integrated and long peripheral IV catheters, including the new Nexiva Closed IV Catheter System with NearPort IV Access.In May 2023, Teleflex Inc. launched two new devices-Arrow VPS Rhythm DLX Device and NaviCurve Stylet-aimed at improving PICC insertion procedures and minimizing complications. The VPS Rhythm DLX Device offers real-time catheter tip location information by utilizing the patient's cardiac electrical activity. The NaviCurve Stylet is designed with an anatomical curve and flexible tip to self-orient to patient anatomy for better PICC advancement into the superior vena cava (SVC) for successful insertion.

Competitive Landscape and Key Companies:Teleflex Inc, BD, B. Braun SE, Terumo Medical Corporation, Medtronic, Fresenius Kabi, Baxter, Vygon SAS, Kimal, and Access Vascular Inc are among the key players highlighted in the vascular access devices market report. Additionally, several other companies have been examined and analyzed to provide a comprehensive view of the market and its ecosystem. These companies are focused on geographic expansion and new product launches to meet the increasing demand from consumers globally and to enhance their product offerings in specialty portfolios. Their global presence enables them to cater to a vast customer base, thereby facilitating market growth.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Vascular Access Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Vascular Access Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Vascular Access Devices Market - Global Market Analysis

  • 6.1 Vascular Access Devices - Global Market Overview
  • 6.2 Vascular Access Devices - Global Market and Forecast to 2030

7. Vascular Access Devices Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 7.1 Overview
  • 7.2 Short Peripheral Intravenous Catheters
  • 7.3 Midline Catheters
  • 7.4 PICC
  • 7.5 Central Catheters
    • 7.5.1 Centrally Inserted central Catheters
    • 7.5.2 Femoral Inserted Central Catheters
  • 7.6 Implantable Ports
  • 7.7 Accessories

8. Vascular Access Devices Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 8.1 Overview
  • 8.2 Drug Administration
  • 8.3 Blood Transfusion
  • 8.4 Fluid and Nutrition Administration
  • 8.5 Others

9. Vascular Access Devices Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Others

10. Vascular Access Devices Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Vascular Access Devices Market Overview
    • 10.1.2 North America Vascular Access Devices Market Revenue and Forecasts to 2030
    • 10.1.3 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Type
    • 10.1.4 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Application
    • 10.1.5 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Vascular Access Devices Market
        • 10.1.6.1.1 United States Vascular Access Devices Market, by Type
        • 10.1.6.1.2 United States Vascular Access Devices Market, by Application
        • 10.1.6.1.3 United States Vascular Access Devices Market, by End User
      • 10.1.6.2 Canada Vascular Access Devices Market
        • 10.1.6.2.1 Canada Vascular Access Devices Market, by Type
        • 10.1.6.2.2 Canada Vascular Access Devices Market, by Application
        • 10.1.6.2.3 Canada Vascular Access Devices Market, by End User
      • 10.1.6.3 Mexico Vascular Access Devices Market
        • 10.1.6.3.1 Mexico Vascular Access Devices Market, by Type
        • 10.1.6.3.2 Mexico Vascular Access Devices Market, by Application
        • 10.1.6.3.3 Mexico Vascular Access Devices Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Vascular Access Devices Market - Key Company Profiles

  • 13.1 B Braun Melsungen AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 NIPRO Medical Corporation
  • 13.3 Smiths Medical
  • 13.4 Becton, Dickinson, and Company
  • 13.5 Terumo Corporation
  • 13.6 Teleflex Incorporated
  • 13.7 Edwards Lifesciences Corporation
  • 13.8 AngioDynamics
  • 13.9 Ameco Medical
  • 13.10 Vygon Ltd

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud